期刊文献+

非小细胞肺癌三维适形放疗后急性放射性食管炎相关剂量学因素分析 被引量:7

Dosimetry analysis on radiation-induced acute esophagitis after three-dimensional conformal radiotherapy for non-small cell lung cancer
原文传递
导出
摘要 目的探讨非小细胞肺癌(NSCLC)三维适形放疗后放射性食管炎发生的相关因素,为NSCLC三维适形治疗计划的制定提供参考指标。方法收集2000年8月至2004年12月符合入组条件在本科接受三维适形放疗的NSCLC患者104例,其中鳞癌45例,腺癌20例,针吸活检或气管镜刷片找到癌细胞者33例,未获得病理确诊者6例。其中全程三维适形放疗者46例,58例前程先行传统常规放疗后程再行三维适形放疗。全组患者处方剂量范围60~78Gy,中位剂量66Gy。变量间的相关性分析采用Spearman相关性检验,组问比较采用,检验,Logistic方法进行多元回归分析。结果本组患者放射性食管炎的发生率为46.2%,其中1级32例占30.8%,2级15例占14.4%,3级1例占1.0%。相关性分析表明食管接受的最大剂量、食管接受的平均剂量、照射野内的食管体积、食管U40、V45,V50、V55、V60、LETT45、LETT50、LET55、LETT60与放射性食管炎的发生呈正相关,多因素分析显示食管接受的最大剂量是≥2级放射性食管炎发生的独立性影响因素。结论食管接受的最大剂量、平均剂量、照射野内食管体积、食管V40~V60、食管LETT45~LETT60与放射性食管炎的发生呈正相关,尤其食管接受的最大剂量对预测放射件食管炎发牛右一窄参考价值。 Objective To analyze the related factors with radiation-induced esophagitis after threedimensional conformal radiotherapy for non-small cell lung cancer (NSCLC), in order to explore the predictors for optimizing the treatment planning of NSCLC. Methods From Aug 2000 to Dec 2004, 104 NSCLC patients received radiotherapy and were eligible for this study, 45 cases squamous cell carcinoma, 20 cases adenocarcinoma, 33 cases carrying with cancer cells by test and 6 case with no definitive pathologic feature. 46 patients were treated with three dimensional conformal radiotherapy(3DCRT) , the other 58 patients conventional radiotherapy (CRT) before later-course 3DCRT. All the patients received the prescribed dose between 60-78 Gy and the median dose 66 Gy. The correlation of the variables were evaluated by Spearman relationship analysis. The morbidity of radiation-induced esophagitis was analyzed by x^2 test. The multivariate effect on radiation-induced esophagitis was statistically processed by Logistic regression model. Results In 104 patients, the morbidity of radiation- induced esophagitis was 46.2% , including 32 cases at grade 1, 15 cases at grade 2, 1 case at grade 3. Univariate analysis showed the maximal and mean dose of esophagus, the volume of esophagus irradiated, the values of V40, V45, V50, V55, V60, LETT45, LETT50, LETT55, LETT60 for the esophagus were correlated with radiation-induced esophagitis. Logistic regression model showed that the maximum dose received by the esophagus was the independent factor of ≥2 grade radiation-induced esophagitis. Conclusions The maxmal dose of esophagus received might be the important factor of radiation-induced esophagitis.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2010年第1期50-53,共4页 Chinese Journal of Radiological Medicine and Protection
基金 国家自然科学基金(30870743) 河北省自然科学基金(C2005000802)
关键词 非小细胞肺癌 三维适形放疗 放射性食管炎 剂量体积直方图 Non-small cell lung cancer Three dimensional conformal radiotherapy Radiation-induced esophagitis DVH
  • 相关文献

参考文献7

  • 1Giraud P, Antoine M, Larrouy A, et al. Evaluation of microscopic tumor extension in non small cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys, 2000, 48(4) :1015-1024.
  • 2封巍,祝淑钗,翟福山,邱嵘,李娟,王玉祥.三维适形放疗非小细胞肺癌所致食管损伤相关因素分析[J].中华放射肿瘤学杂志,2005,14(2):94-98. 被引量:17
  • 3Chapet O, Kong FM, Lee JS, et al. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small lung cancer. Radiother Oncol, 2005, 77(2):176-181.
  • 4Hirota S, Tsujino K, Endo M, et al. Dosimetfic predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with earboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys, 2001, 51 (2) :291-295.
  • 5Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 1991, 21(1) :109-122.
  • 6Patel AB, Edelman MJ, Kwok Y, et al. Predictors of acute esophagitis in patients with non-small cell lung carcinoma treated with concurrent chemotherapy and hyperfractiona radiotherapy followed by surgery, lnt J Radiat Oncol Biol Phys, 2004, 60 (4) :1106-1112.
  • 7Singh AK, Lockett MA, Bradley JD, et al. Predictors of radiation-induced esophageal toxicity in patients with non-small- cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys, 2003, 55 (2): 337-341.

二级参考文献9

  • 1Barton M.Tables of equivalent dose in 2 Gy fractions a simple application of linear quadratic formula.Int J Radiat Oncol Biol Phys,1995,31:371-378.
  • 2Byhardt RW,Scott C,Sause WT,et al.Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.Int J Radiat Oncol Biol Phys,1998, 42:469-478.
  • 3Saunders M, Dische S,Barrett A,et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial.Lancet,1997,350:161.
  • 4Singh AK, Lockett MA,Bradley JD,et al.Radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.Int J Radiat Oncol Biol Phys,2003,55:337-341.
  • 5Maguire PD,Sibley GS,Zhou SM,et al.Clinical and dosimetric predictors of radiation-induced esophageal toxicity.Int J Radiat Oncol Biol Phys,1999, 45:97-103.
  • 6Werner-Wasik M, Pequignot E,Leeper D.Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of the irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.Int J Radiat Oncol Biol Phys,2000,48:689-696.
  • 7Hirota S, Tsujino K, Endo M,et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy.Int J Radiat Oncol Biol Phys,2001,51:291-295.
  • 8Emami B,Lyman J,Brown A,et al.Tolerance of normal tissue to therapeutic irradiation.Int J Radiat Oncol Biol Phys,1991,21:109-122.
  • 9Hirota S,Tsujino K,Hishikawa Y,et al.Endoscopic findings radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies.Radiother Oncol,2001,58:273-278.

共引文献16

同被引文献65

  • 1蔡峰,李光,赵玉霞,党军,姚雷,吴春丽.三维适形放疗对Ⅲ期非小细胞肺癌肺功能影响的初步观察[J].中华放射肿瘤学杂志,2006,15(6):440-443. 被引量:12
  • 2Price KA,Azzoli CG,Gaspar LE. Chemoradiation for unresectable stageDI non-small cell lung cancer[ J]. Semin Thorac Cardiovasc Surg,2008;20(3):204-9.
  • 3Hansen 0 ,Paarup H,Sorensen P,ei al. Curative radiotherapy of local ad-vanced non-small-cell lung cancer:eight years of experience from Odense[J]. Ugeskr Laeger,2005;167(37):3497-502.
  • 4Cunningham D, Chau I, Stocken DD, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer [ J ]. J Clin Oncol, 2009, 27:5513-5518.
  • 5Li CP, Chao Y, Chi KH, et al. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer:gemcitabine versus 5-fluorouracil, a randomized controlled study [ J ]. Int J Radiat Oncol Biol Phys, 2003, 57:98-104.
  • 6Auperin A, Le Pechoux C, Rolland E, et al. Meta analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer [ J]. J Clin Oncol, 2010, 28 ( 13 ) :2181-2190.
  • 7Zhu J, Zhang ZC, Li BS, et al. Analysis of acute radiation- induced esophagitis in non-small-cell lung cancerpatients using the Lyman NTCP model [ J ]. Radiother Oncol, 2010,97 ( 3 ) : 449-454.
  • 8Zhang ZC, Xu J, Li BS, et al. Clinical and dosimetric risk factors of acute esophagitis in patients treated with 3-dimensional conformal radiotherapy for non-small-cell lung cancer[ J]. Am J Clin Oncol, 2010,33 ( 3 ) :271-275.
  • 9Takeda K, Nemoto K, Saito H, et al. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy [J]. Int J Radiat Oncol Biol Phys,2005,62(3) :626-629.
  • 10Rowell NP, Oi:ourke NP. Concurrent chemoradiotherapy in non- small cell lung cancer[ J]. Cochrane Database Syst Rev, 2004, 6 : CD002140.

引证文献7

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部